Ishara Investments LP Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$87.5M

Holdings

38

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (38 positions)

#StockSharesValue% PortfolioType
1
PRAXPRAXIS PRECISION MEDICINES I
40,000$11.8M13.48%
2
XERSXERIS BIOPHARMA HOLDINGS INC
800,000$6.3M7.18%
3
BMRNBIOMARIN PHARMACEUTICAL INC
100,000$5.9M6.80%
4
AM6AMICUS THERAPEUTICS INC
360,000$5.1M5.86%
5
ACADACADIA PHARMACEUTICALS INC
160,000$4.3M4.89%
6
ANNXANNEXON INC
750,000$3.8M4.31%
7
NUVBNUVATION BIO INC
400,000$3.6M4.10%
8
BBIOBRIDGEBIO PHARMA INC
36,000$2.8M3.15%
9
PTCTPTC THERAPEUTICS INC
36,000$2.7M3.13%
10
UTHUNITED THERAPEUTICS CORP DEL
5,500$2.7M3.06%
11
BCRXBIOCRYST PHARMACEUTICALS INC
300,000$2.3M2.68%
12
PCVXVAXCYTE INC
50,000$2.3M2.64%
13
GMABGENMAB A/S
70,000$2.2M2.47%
14
SNDXSYNDAX PHARMACEUTICALS INC
100,000$2.1M2.40%
15
VSTMVERASTEM INC
270,000$2.1M2.38%
16
TARSTARSUS PHARMACEUTICALS INC
24,000$2.0M2.25%
17
APOGAPOGEE ENTERPRISES INC
25,000$1.9M2.16%
18
ZNTLZENTALIS PHARMACEUTICALS INC
1,320,000$1.8M2.04%
19
IM8NINSMED INC
10,000$1.7M1.99%
20
HTDCORCEPT THERAPEUTICS INC
44,000$1.5M1.75%Call
21
SLNSILENCE THERAPEUTICS PLC
240,000$1.5M1.67%
22
EWTXEDGEWISE THERAPEUTICS INC
58,000$1.4M1.65%
23
BEAMBEAM THERAPEUTICS INC
50,000$1.4M1.58%
24
ORICORIC PHARMACEUTICALS INC
160,000$1.3M1.50%
25
APLSAPELLIS PHARMACEUTICALS INC
50,000$1.3M1.44%
26
DNLIDENALI THERAPEUTICS INC
70,000$1.2M1.32%
27
RAREULTRAGENYX PHARMACEUTICAL IN
50,000$1.1M1.31%
28
ASNDASCENDIS PHARMA A/S
5,000$1.1M1.22%
29
NAMSNEWAMSTERDAM PHARMA COMPANY
30,000$1.1M1.20%
30
LXRXLEXICON PHARMACEUTICALS INC
880,000$1.0M1.16%
31
BHVNBIOHAVEN LTD
88,000$993K1.14%
32
DNTHDIANTHUS THERAPEUTICS INC
24,000$989K1.13%
33
NKTRNEKTAR THERAPEUTICS
20,000$845K0.97%
34
IMTXIMMATICS N.V
80,000$840K0.96%
35
AGIOAGIOS PHARMACEUTICALS INC
30,000$816K0.93%
36
IMVTIMMUNOVANT INC
30,000$762K0.87%
37
OLMAOLEMA PHARMACEUTICALS INC
30,000$750K0.86%
38
ARQTARCUTIS BIOTHERAPEUTICS INC
12,000$348K0.40%